scholarly journals Economic evaluation of nivolumab as a second-line treatment for advanced renal cell carcinoma from US and Chinese perspectives

Cancer ◽  
2017 ◽  
Vol 123 (14) ◽  
pp. 2634-2641 ◽  
Author(s):  
Xiao Min Wan ◽  
Liu Bao Peng ◽  
Jin An Ma ◽  
Yuan Jian Li
Keyword(s):  
Renal Cell Carcinoma ◽  
Economic Evaluation ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Line Treatment ◽  
Second Line

scholarly journals Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinoma

2015 ◽  
Vol 7 (5) ◽  
pp. 286-294 ◽  
Author(s):  
Daniele Alesini ◽  
Claudia Mosillo ◽  
Giuseppe Naso ◽  
Enrico Cortesi ◽  
Roberto Iacovelli
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Experience ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Line Treatment ◽  
Second Line

Rationale and Protocol of SOAP: A Phase II Study to Evaluate the Efficacy of Sorafenib as Second-Line Treatment after Pazopanib in Patients with Advanced Renal Cell Carcinoma

2014 ◽  
Vol 100 (6) ◽  
pp. e282-e285
Author(s):  
Roberto Iacovelli ◽  
Elena Verzoni ◽  
Paolo Grassi ◽  
Alessio Farcomeni ◽  
Filippo de Braud ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma ◽  
Line Treatment ◽  
Second Line

scholarly journals Cost-Effectiveness of Sorafenib for Second-Line Treatment of Advanced Renal Cell Carcinoma

2010 ◽  
Vol 13 (1) ◽  
pp. 55-60 ◽  
Author(s):  
Martin Hoyle ◽  
Colin Green ◽  
Jo Thompson-Coon ◽  
Zulian Liu ◽  
Karen Welch ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cost Effectiveness ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Line Treatment ◽  
Second Line

Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma

2012 ◽  
Vol 15 (6) ◽  
pp. 1139-1148 ◽  
Author(s):  
Michael K. Wong ◽  
Ateesha F. Mohamed ◽  
A. Brett Hauber ◽  
Jui-Chen Yang ◽  
Zhimei Liu ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Progression Free Survival ◽  
Advanced Renal Cell Carcinoma ◽  
Line Treatment ◽  
Second Line ◽  
Free Survival

scholarly journals Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece

2016 ◽  
Vol 19 (7) ◽  
pp. A732
Author(s):  
A Solakidi ◽  
G Kourlaba ◽  
L Kontovinis ◽  
K Koutsoukos ◽  
E Bournakis ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Economic Evaluation ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
Second Line
Sign in / Sign up

Export Citation Format

Share Document